NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd.verified

NRSN

Price:

$1.2

Market Cap:

$29.60M

NeuroSense Therapeutics Ltd., a clinical-stage biotechnology company, focuses on the discovery and development of treatment for patients suffering from debilitating neurodegenerative diseases. Its lead product, PrimeC, is a novel oral formulation that has completed Phase IIa clinical trials for the treatment of amyotrophic lateral sclerosis. The company's preclinical pipeline includes StabiliC for the treatment of Parkinson's disease; and CogniC for the treatment of Alzheimer's disease. NeuroSense Therapeutics Ltd. was incorporated in 2017 and is headquartered in Herzliya, Israel.

Industry

Biotechnology

IPO Date

2021-12-09

Stock Exchange

NASDAQ

Ticker

NRSN

The ROE as of December 2025 (TTM) for NeuroSense Therapeutics Ltd. (NRSN) is 2.72%

According to NeuroSense Therapeutics Ltd.’s latest financial reports and current stock price. The company's current ROE is 2.72%. This represents a change of 1.09% compared to the average of 228.46% of the last 4 quarters.

NeuroSense Therapeutics Ltd. (NRSN) Historical ROE (quarterly & annually)

How has NRSN ROE performed in the past?

The mean historical ROE of NeuroSense Therapeutics Ltd. over the last ten years is -113.87%. The current 2.72% ROE has changed -2489.11% with respect to the historical average. Over the past ten years (40 quarters), NRSN's ROE was at its highest in in the March 2025 quarter at 453.66%. The ROE was at its lowest in in the September 2023 quarter at -400.00%.

Quarterly (TTM)
Annual

Average

-113.87%

Median

-176.64%

Minimum

-429.14%

Maximum

539.33%

NeuroSense Therapeutics Ltd. (NRSN) ROE by Quarter and Year

Discovering the peaks and valleys of NeuroSense Therapeutics Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 389.44%

Maximum Annual ROE = 539.33%

Minimum Annual Increase = -345.58%

Minimum Annual ROE = -429.14%

Quarterly (TTM)
Annual
YearROEChange
2024-395.28%-173.29%
2023539.33%-345.58%
2022-219.61%389.44%
2021-44.87%-89.54%
2020-429.14%221.06%

NeuroSense Therapeutics Ltd. (NRSN) Average ROE

How has NRSN ROE performed in the past?

The current ROE of NeuroSense Therapeutics Ltd. (NRSN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-25.19%

5-year avg

-109.91%

10-year avg

-113.87%

NeuroSense Therapeutics Ltd. (NRSN) ROE vs. Peers

How is NRSN’s ROE compared to its peers?

NeuroSense Therapeutics Ltd.’s ROE is greater than NeurAxis, Inc. (-340.23%), greater than Klotho Neurosciences, Inc. (-201.59%), greater than CollPlant Biotechnologies Ltd. (-102.03%), greater than Exicure, Inc. (-110.40%), greater than Cadrenal Therapeutics, Inc. Common Stock (-279.52%), greater than Enlivex Therapeutics Ltd. (-62.91%), greater than Sonnet BioTherapeutics Holdings, Inc. (-4648.06%), greater than Minerva Neurosciences, Inc. (-0.00%), greater than Rallybio Corporation (-71.66%), greater than TAO Synergies Inc. (-256.58%),

Build a custom stock screener for NeuroSense Therapeutics Ltd. (NRSN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NeuroSense Therapeutics Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

NeuroSense Therapeutics Ltd. (NRSN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like NeuroSense Therapeutics Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is NeuroSense Therapeutics Ltd.'s ROE?

How is the ROE calculated for NeuroSense Therapeutics Ltd. (NRSN)?

What is the highest ROE for NeuroSense Therapeutics Ltd. (NRSN)?

What is the 3-year average ROE for NeuroSense Therapeutics Ltd. (NRSN)?

What is the 5-year average ROE for NeuroSense Therapeutics Ltd. (NRSN)?

How does the current ROE for NeuroSense Therapeutics Ltd. (NRSN) compare to its historical average?